$Lipella Pharmaceuticals(LIPO.US)$Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis 2 MINUTES AGO, 8:00 AM EDT VIA GLOBENEWSWIRE
$Lipella Pharmaceuticals(LIPO.US)$10% Shareholder Kaufman Jonathan H purchased 55,000 shares of Common Stocks on Mar 18, 19, 2024 at an average price of $0.8264 for a total value of $45,451.5.
$Lipella Pharmaceuticals(LIPO.US)$Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline 3 MINUTES AGO, 8:00 AM EST VIA GLOBENEWSWIRE
$Lipella Pharmaceuticals(LIPO.US)$This has been trading basically sideways since the FDA granted orphan drug! Im thinking one of these days it will actually get a nice boost in price
Trytosaveabit樓主 : 公司預計 5 月 21 日與 FDA 會面